当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析 - 资产负债表

安科生物

(300009)

  

流通市值:118.77亿  总市值:163.83亿
流通股本:12.16亿   总股本:16.77亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金260,226,567.56266,241,504.44275,605,526.68373,617,457.87
应收票据及应收账款550,228,951.09501,122,070.51480,377,893.47440,431,600.31
应收账款550,228,951.09501,122,070.51480,377,893.47440,431,600.31
应收款项融资47,210,084.3722,046,724.2460,068,584.7353,425,369.66
预付款项25,677,806.1953,876,157.2349,789,796.9465,576,507.01
其他应收款合计9,002,811.5530,984,519.2910,592,368.5412,309,589.56
存货235,215,374.68237,388,257.41238,450,923.82214,479,624.94
其他流动资产2,349,649.98590,170.61815,700.371,291,763.23
流动资产平衡项目0000
流动资产合计2,325,483,458.752,090,507,909.851,854,095,806.782,114,109,026.09
非流动资产:
债权投资72,157,777.77---
长期股权投资167,344,181.81190,995,431.86188,557,565.83191,535,822.05
其他非流动金融资产164,881,340.19166,480,000166,480,000151,480,000
投资性房地产8,110,204.318,329,504.1110,077,368.0210,321,712.31
固定资产706,153,841.12703,946,804.87680,558,485.25690,031,186.92
在建工程672,507,138.6541,731,331.03485,097,548.21474,797,309.55
使用权资产54,887,772.7736,956,302.7133,343,127.5627,365,831.26
无形资产450,361,623.07272,271,834.73273,348,446.9271,021,294.68
开发支出215,952,222.05435,060,666.38422,878,292.11414,617,747.74
商誉66,556,732.2457,602,564.9257,602,564.9257,602,564.92
长期待摊费用7,846,470.487,583,018.777,926,361.018,496,050.66
递延所得税资产29,532,200.2751,298,189.3450,825,693.9745,159,242.9
其他非流动资产8,985,522.6128,469,763.2521,773,427.4423,791,218.97
非流动资产平衡项目0000
非流动资产合计2,625,277,027.292,500,725,411.972,398,468,881.222,366,219,981.96
资产平衡项目0000
资产总计4,950,760,486.044,591,233,321.824,252,564,6884,480,329,008.05
流动负债:
应付票据及应付账款211,703,603.46146,546,645.32150,173,720.77153,672,055.56
其中:应付票据14,920,000---
应付账款196,783,603.46146,546,645.32150,173,720.77153,672,055.56
合同负债24,429,985.7722,514,096.7923,299,676.6415,722,653.45
应付职工薪酬198,343,818.21103,440,038.9677,063,660.57135,513,048.27
应交税费68,281,633.21108,644,429.7382,548,393.3682,027,406.04
其他应付款合计333,195,150.24295,788,082.36303,553,640.6290,207,138.89
应付股利8,689,5658,698,10011,169,920-
一年内到期的非流动负债8,810,791.266,372,959.676,717,032.225,732,918.37
其他流动负债2,315,906.712,033,882.31,788,710.661,548,371.8
流动负债平衡项目0000
流动负债合计847,080,888.86685,340,135.13645,144,834.82684,423,592.38
非流动负债:
租赁负债47,817,285.9331,918,254.527,179,870.2422,283,215.76
递延收益113,522,377.24108,894,399.82111,180,754.95112,187,937.45
递延所得税负债10,008,027.7141,379,391.9740,013,266.2439,175,937.01
非流动负债平衡项目0000
非流动负债合计171,347,690.88182,192,046.29178,373,891.43173,647,090.22
负债平衡项目0000
负债合计1,018,428,579.74867,532,181.42823,518,726.25858,070,682.6
所有者权益(或股东权益):
实收资本(或股本)1,676,826,7581,673,257,9581,673,257,9581,673,257,958
资本公积519,816,627.91482,938,290.77458,321,155.72431,054,574.71
减:库存股226,215,180.61207,407,604.61207,407,604.61207,407,604.61
盈余公积369,201,720.76292,827,170.6292,827,170.6292,832,788.22
未分配利润1,397,769,620.951,281,324,447.341,023,266,148.791,229,827,584.05
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,737,399,547.013,522,940,262.13,240,264,828.53,419,565,300.37
少数股东权益194,932,359.29200,760,878.3188,781,133.25202,693,025.08
股东权益平衡项目0000
股东权益合计3,932,331,906.33,723,701,140.43,429,045,961.753,622,258,325.45
负债和股东权益合计4,950,760,486.044,591,233,321.824,252,564,6884,480,329,008.05
公告日期2024-03-282023-10-252023-08-242023-04-28
审计意见(境内)标准无保留意见
TOP↑